Leaflet: Information for the User
Ilvico Coated Tablets
paracetamol / caffeine / brompheniramine maleate
Read this leaflet carefully before you start to take this medicine, because it contains important information for you.
Follow exactly the administration instructions for the medicine contained in this leaflet or those indicated by your doctor or pharmacist.
5. Storage of Ilvico.
Ilvico belongs to the group of combined medications for the common cold.
It is indicated for symptomatic relief in gripal and catarrhal processes that are accompanied by fever, mild to moderate pain, and nasal secretion.
Consult a doctor if symptoms worsen or do not improve after 5 days.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Ilvico.
Inform your doctor immediately if you experience any of the following during treatment with Ilvico:
Severe diseases, such as severe kidney failure or sepsis (when bacteria and their toxins circulate in the blood, causing damage to organs), or if you have malnutrition, chronic alcoholism, or are also taking flucloxacillin (an antibiotic). A severe disease called metabolic acidosis (a blood and fluid anomaly) has been reported in patients in these situations when using paracetamol at regular doses for a prolonged period or when taking paracetamol with flucloxacillin. Symptoms of metabolic acidosis may include:
Severe respiratory distress with deep and rapid breathing, drowsiness, feeling unwell (nausea), and vomiting.
Taking Ilvico with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. Many other medications can affect liver function and increase the risk of liver toxicity.
Particularly, if you are taking any of the following medications, as it may be necessary to modify the dose of some of them or even discontinue treatment:
Interference with analytical tests
Inform your doctor if you are to undergo any analytical tests (including blood and urine tests), as this medication may alter the results.
Taking Ilvico with food and drinks
Coffee, tea, chocolate, or cola beverages contain caffeine. Therefore, it is recommended to moderate your consumption of these products while taking Ilvico.Consuming up to 400 mg of caffeine per day in healthy adults is considered safe, so consider the total caffeine content in other foods or products while taking this medication.
Taking Ilvico by patients who regularly consume alcohol (three or more alcoholic beverages -beer, wine, liquor...- per day) may cause liver damage.
Concurrent consumption of Ilvico with alcoholic beverages may increase its adverse effects.
Taking this medication with food does not affect its efficacy.
Use in children
Do not administer to children under 12 years old.
Use in people over 65 years old
Consult your doctor before taking bromfeniramine, as you may experience confusion and may need to take a lower daily dose. People over 65 years old are more prone to experiencing adverse effects. Consult your doctorbefore taking this medication.
Pregnancy and breastfeeding
Pregnant or breastfeeding women cannot take this medication. It will only be considered for use under medical recommendation and strict supervision, if the benefits outweigh the risks.
Driving and operating machinery
This medication may cause drowsiness, dizziness, or blurred vision, especially if you consume alcoholic beverages while taking this medication. If the medication causes these effects, do not drive or operate hazardous tools or machinery while taking this medication.
Ilvico contains carboxymethylcellulose sodium (type A)
This medication contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially 'sodium-free'.
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
2 tablets (650 mg of paracetamol) every 8 hours. Do not take more than 6 tablets in 24 hours. Do not take more than 3 g of paracetamol in 24 hours (see section 2, "Warnings and precautions").
Adolescents 12 years of age and older
1 tablet every 6 or 8 hours. Do not take more than 4 tablets in 24 hours.
Children under 12 years of age
They cannot take this medication.
This medication is taken orally.
The tablets will be taken with a little water.
Discontinue treatment once the symptoms have disappeared.
If symptoms worsen or persist for more than 5 days of treatment, you must consult a doctor.
If you take more Ilvico than you should
If an overdose has been taken, go quickly to a medical center, even if no symptoms are noted, as they often do not appear until 3 days after the overdose, even in cases of severe poisoning. Taking too much paracetamol can cause severe liver damage.
The symptoms of an overdose may be: excitement, discomfort, diarrhea, abdominal pain, convulsions, dizziness, nausea, vomiting, loss of appetite, yellow discoloration of the skin and eyes (jaundice), drowsiness, disorientation, and sweating.
The treatment of an overdose is more effective if initiated within 4 hours of taking the medication.
Patients undergoing barbiturate treatment or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicological Information Service (phone 91 562 04 20), indicating the medication and the amount ingested.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Side effects are rare with paracetamol.
Stop taking the product and contact your doctor immediately if you notice:
- Allergic reactions, such as skin rashes, itching, urticaria (hives or nettle rash), swelling of the lips, tongue, or throat, or difficulty breathing, anaphylaxis.
- An increase in the number of nosebleeds or notice that you are getting bruises or bleeding more easily.
Rare cases of severe skin reactions have been reported. If a skin reaction occurs, discontinue use and seek medical help immediately. –
You must stop treatment immediately if you experience dizziness or palpitations (abnormally strong heartbeats).
Frequent disorders (observed between 1 and 10 people in every 100):
- Drowsiness, headache, blurred vision, increased respiratory secretions, dry mouth, stomach pain. Some patients, particularly those with an enlarged prostate, may have difficulty urinating (urinary retention).
Rare disorders (observed between 1 and 10 people in every 10,000):
- Heart rhythm disorders.
- Decreased blood pressure (hypotension).
- Feeling of fainting -
Discomfort.
Convulsions and tremors.
- Liver function alterations.
Very rare disorders (observed in fewer than 1 in 10,000 people):
- Decreased levels of some blood cells, which may increase the likelihood of infections or include a type of anemia.
- Decreased blood sugar
- Yellow discoloration of the skin.
-Cloudy urine, burning sensation while urinating.
- Allergy.
Rare cases of severe skin reactions have been reported. If a skin reaction occurs, stop using it and seek medical help immediately.
Other side effects related to caffeine have been observed, for which the exact frequency cannot be established. The most commonly observed effects have been: insomnia, restlessness, nervousness, irritability, excitement, and disorientation. Nausea, vomiting, and stomach irritation have also been observed.
You must stop treatment immediately if you feel dizzy or experience palpitations (abnormally strong heartbeats).
Unknown frequency (cannot be estimated from available data): A serious disease that can make the blood more acidic (metabolic acidosis) in patients with severe disease using paracetamol (see section 2).
Reporting of adverse reactions:
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is a possible adverse reaction that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use: http://www.notificaram.es. By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Do not store at a temperature above 86°F (30°C).
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
The active principles are paracetamol 325 mg, caffeine 30 mg, and brompheniramine maleate 3 mg.
The other components are microcrystalline cellulose, sodium carboxymethylcellulose (type A) (derived from potato starch), crospovidone, hypromellose, powdered cellulose, magnesium stearate, glycerol (E-422), anhydrous colloidal silica, titanium dioxide (E171), macrogol, and talc.
Appearance of the product and contents of the packaging
Ilvico are white coated tablets, presented in blister packs, packaged in boxes of 20 tablets.
Holder of the marketing authorization
Laboratorios Vicks, S.L.
Avda. Bruselas, 24
28108 Alcobendas (Madrid) España
Responsible for manufacturing
P&G Health Austria GmbH & Co. OG
Hösslgasse 20
9800 Spittal an der Drau
Austria
Local representative
Procter & Gamble España, S.L.U.
Avda. Bruselas, 24
28108 Alcobendas (Madrid) España
Last review date of this leaflet:January 2025
The detailed information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.